Important Dates
Early Bird Registration :20th September 2026
Paper Submission Deadline :25th September 2026
Last Date of Registration : 5th October 2026
Date of Conference : 20th - 21st October 2026
Conference Session Tracks
Aligned with
UN Sustainable Development Goals
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 10 — Reduced Inequalities
SDG 11 — Sustainable Cities and Communities
Track 01
Advancements in Personalized Oncology
This track will explore the latest developments in personalized oncology, focusing on tailored treatment strategies based on individual genetic profiles. Discussions will include case studies and innovative approaches to enhance patient outcomes.
Track 02
Biomarkers in Cancer Diagnosis and Treatment
This session will delve into the role of biomarkers in the early detection and management of cancer. Researchers will present findings on novel biomarkers that can predict treatment responses and disease progression.
Track 03
Immunotherapy: Current Trends and Future Directions
This track will examine the evolving landscape of immunotherapy in oncology, highlighting recent breakthroughs and clinical applications. Participants will engage in discussions about the challenges and opportunities in harnessing the immune system to combat cancer.
Track 04
Tumor Microenvironment and Cancer Biology
This session will focus on the complex interactions within the tumor microenvironment and their implications for cancer progression and therapy. Presentations will cover cellular and molecular mechanisms that influence tumor behavior.
Track 05
Precision Medicine in Oncology: Strategies and Challenges
This track will address the implementation of precision medicine in oncology, discussing both the strategies employed and the challenges faced in clinical practice. Experts will share insights on integrating genomic data into treatment plans.
Track 06
Translational Oncology: Bridging Research and Clinical Practice
This session will highlight the importance of translational research in oncology, focusing on how laboratory discoveries can be effectively translated into clinical applications. Participants will discuss successful case studies and future directions.
Track 07
Innovations in Cancer Treatment Modalities
This track will showcase cutting-edge treatment modalities in oncology, including novel chemotherapeutic agents and targeted therapies. Researchers will present their findings on efficacy and safety profiles of these innovative treatments.
Track 08
Genomic and Epigenomic Alterations in Cancer
This session will explore the role of genomic and epigenomic alterations in cancer development and progression. Presentations will focus on how these changes can inform therapeutic strategies and patient management.
Track 09
Pediatric Oncology: Unique Challenges and Innovations
This track will address the unique challenges faced in pediatric oncology, including the need for tailored treatment approaches for younger patients. Discussions will include recent advancements and ongoing research in this critical area.
Track 10
Health Disparities in Cancer Care
This session will examine the disparities in cancer care and outcomes across different populations. Researchers will present data and strategies aimed at addressing these inequities to improve access and treatment for all patients.
Track 11
Future Directions in Cancer Research
This track will provide a platform for discussing emerging trends and future directions in cancer research. Experts will share their visions for the next decade in oncology, including potential breakthroughs and areas of focus.